SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Rosenfeld K.) "

Sökning: WFRF:(Rosenfeld K.)

  • Resultat 1-10 av 68
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • 2017
  • swepub:Mat__t
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  • Fresard, Laure, et al. (författare)
  • Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts
  • 2019
  • Ingår i: Nature Medicine. - : NATURE PUBLISHING GROUP. - 1078-8956 .- 1546-170X. ; 25:6, s. 911-919
  • Tidskriftsartikel (refereegranskat)abstract
    • It is estimated that 350 million individuals worldwide suffer from rare diseases, which are predominantly caused by mutation in a single gene(1). The current molecular diagnostic rate is estimated at 50%, with whole-exome sequencing (WES) among the most successful approaches(2-5). For patients in whom WES is uninformative, RNA sequencing (RNA-seq) has shown diagnostic utility in specific tissues and diseases(6-8). This includes muscle biopsies from patients with undiagnosed rare muscle disorders(6,9), and cultured fibroblasts from patients with mitochondrial disorders(7). However, for many individuals, biopsies are not performed for clinical care, and tissues are difficult to access. We sought to assess the utility of RNA-seq from blood as a diagnostic tool for rare diseases of different pathophysiologies. We generated whole-blood RNA-seq from 94 individuals with undiagnosed rare diseases spanning 16 diverse disease categories. We developed a robust approach to compare data from these individuals with large sets of RNA-seq data for controls (n = 1,594 unrelated controls and n = 49 family members) and demonstrated the impacts of expression, splicing, gene and variant filtering strategies on disease gene identification. Across our cohort, we observed that RNA-seq yields a 7.5% diagnostic rate, and an additional 16.7% with improved candidate gene resolution.
  •  
10.
  • Christiansen, J. S., et al. (författare)
  • Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations
  • 2016
  • Ingår i: European Journal of Endocrinology. - : Oxford University Press (OUP). - 0804-4643 .- 1479-683X. ; 174:6
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: The Growth Hormone (GH) Research Society (GRS) convened a workshop to address important issues regarding trial design, efficacy, and safety of long-acting growth hormone preparations (LAGH). Participants: A closed meeting of 55 international scientists with expertise in GH, including pediatric and adult endocrinologists, basic scientists, regulatory scientists, and participants from the pharmaceutical industry. Evidence: Current literature was reviewed for gaps in knowledge. Expert opinion was used to suggest studies required to address potential safety and efficacy issues. Consensus process: Following plenary presentations summarizing the literature, breakout groups discussed questions framed by the planning committee. Attendees reconvened after each breakout session to share group reports. A writing team compiled the breakout session reports into a draft document that was discussed and revised in an open forum on the concluding day. This was edited further and then circulated to attendees from academic institutions for review after the meeting. Participants from pharmaceutical companies did not participate in the planning, writing, or in the discussions and text revision on the final day of the workshop. Scientists from industry and regulatory agencies reviewed the manuscript to identify any factual errors. Conclusions: LAGH compounds may represent an advance over daily GH injections because of increased convenience and differing phamacodynamic properties, providing the potential for improved adherence and outcomes. Better methods to assess adherence must be developed and validated. Long-term surveillance registries that include assessment of efficacy, cost-benefit, disease burden, quality of life, and safety are essential for understanding the impact of sustained exposure to LAGH preparations.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 68
Typ av publikation
tidskriftsartikel (62)
konferensbidrag (3)
forskningsöversikt (2)
Typ av innehåll
refereegranskat (58)
övrigt vetenskapligt/konstnärligt (9)
Författare/redaktör
Kvarnung, M (7)
Nordgren, A (6)
Nordenskjold, M (6)
Gunnarsson, Ronny K, ... (6)
Lindstrand, A (6)
Ho, K. (6)
visa fler...
Rosenfeld, RG (6)
Pierce, K (6)
Romano, C (6)
Eichler, EE (6)
Söderström, Mats (5)
Rosenfeld, R (5)
Bidlingmaier, M. (5)
Juul, A. (5)
Saenger, P. (5)
Miller, M. (4)
Aboyans, V (4)
Polinder, S (4)
Vos, T (4)
Cohen, P (4)
Stocchetti, Nino (4)
Menon, David K. (4)
Grimberg, A. (4)
Citerio, Giuseppe (4)
Büki, Andras, 1966- (4)
Rosenfeld, MG (4)
Meyfroidt, Geert (4)
Smith, E (4)
Hutchinson, Peter (4)
Rosenfeld, Mark, 194 ... (4)
O'Donnell, M (4)
Bernier, RA (4)
Taccone, Fabio Silvi ... (4)
Robertson, Claudia (4)
Guo, H (4)
Diringer, Michael (4)
Videtta, Walter (4)
Aguilera, Sergio (4)
Cooper, D. Jamie (4)
Figaji, Anthony (4)
Gao, Guoyi (4)
Ghajar, Jamshid (4)
Harris, Odette (4)
Hoffer, Alan (4)
Joseph, Mathew (4)
Kitagawa, Ryan (4)
Manley, Geoffrey (4)
Michael, Daniel B. (4)
Oddo, Mauro (4)
Rosenfeld, Jeffrey V ... (4)
visa färre...
Lärosäte
Karolinska Institutet (32)
Göteborgs universitet (13)
Lunds universitet (8)
Linköpings universitet (7)
Uppsala universitet (5)
Örebro universitet (5)
visa fler...
Umeå universitet (3)
Kungliga Tekniska Högskolan (1)
Stockholms universitet (1)
Chalmers tekniska högskola (1)
Högskolan i Borås (1)
visa färre...
Språk
Engelska (68)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (25)
Naturvetenskap (3)
Teknik (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy